Even though the PDL1/GSK3β immune complex has been observed in tumor cells, it is still unclear whether this interaction occurs in the brain and whether GSK3β is the direct downstream target of PD1/PDL1 to regulate tau hyperphosphorylation in AD. This evidence concerns the gene MAPT and Alzheimer disease.